Phreesia (NYSE:PHR – Get Free Report) and MSCI (NYSE:MSCI – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability. Institutional and Insider Ownership 94.4% of Phreesia shares are owned […]
Candriam S.C.A. acquired a new position in Phreesia, Inc. (NYSE:PHR – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 70,000 shares of the company’s stock, valued at approximately $2,171,000. Candriam S.C.A. owned approximately 0.13% of Phreesia at the […]
Shares of Phreesia, Inc. (NYSE:PHR – Get Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen analysts that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average 1-year price objective among […]